Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Molecular Pathogenesis and New Interventions in Scleroderma

    Forecasted

    Molecular Pathogenesis and New Interventions in Scleroderma supports researchers studying disease mechanisms and developing and pilot testing innovative therapies to advance understanding and treatment of scleroderma.

    Browse similar grants
    Foundation Grants for Biomedical ResearchCancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Scleroderma Research Foundation

    Due Dates (Anticipated): March 2027 (Application deadline)

    Funding Amounts: SRF01: up to $200,000/year for up to three years; SRF02 and SRF03: up to $75,000/year for up to two years

    Summary: Supports research on scleroderma pathogenesis and the development and pilot testing of hypothesis-driven, innovative therapies.

    Key Information: Award recipients must attend the annual SRF Workshop to present their research.


    Description

    The Scleroderma Research Foundation (SRF) supports investigator-initiated, exploratory/developmental, and new faculty research to advance understanding of scleroderma and develop innovative therapeutic approaches. The program encourages cross-disciplinary and cross-institutional collaboration, welcomes scientists new to scleroderma, and seeks to bring new technologies and thinking into the field.

    Research interests include immune activation, fibrosis, vascular abnormalities, genomic factors, autoantibodies, biomarkers, and diagnostic methods. Projects may characterize clinical subgroups and organ complications, develop cell-based or animal models, or test mechanistic hypotheses using currently available drugs. Smaller clinical studies may include observational or retrospective research, preclinical therapy development, or preliminary assessment of toxicity and efficacy in limited numbers of patients.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.